Product Overview:
This blend combines Ipamorelin, a selective growth hormone secretagogue (GHRP), with CJC-1295 without DAC, a growth hormone-releasing hormone (GHRH) analog. Together, they are studied for their synergistic effect on stimulating natural growth hormone (GH) release.
-
Ipamorelin selectively stimulates GH release via the ghrelin receptor without increasing cortisol or prolactin.
-
CJC-1295 (No DAC) has a shorter half-life but provides a natural GH pulsatility, mimicking physiological rhythms.
The combination is widely used in research exploring muscle regeneration, GH/IGF-1 axis modulation, and age-related endocrine decline.
Applications in Research:
-
Studies on growth hormone optimization and feedback regulation
-
Research models for tissue repair, muscle growth, and recovery
-
Investigations into neuroendocrine aging and GH deficiency
-
Evaluation of pituitary signaling pathways
Storage & Handling:
Store lyophilized peptide blend at -20°C in a dark, dry location.
Reconstitute with bacteriostatic water under sterile conditions. Keep reconstituted solution refrigerated and use promptly. Avoid multiple freeze-thaw cycles.
RESEARCH USE ONLY – LEGAL DISCLAIMER
All Nivo Labs products labeled as Research Use Only (RUO) are intended strictly for laboratory, investigational, and scientific research purposes. These materials are not approved by the FDA and are not intended for human or veterinary use, clinical applications, diagnostic procedures, or therapeutic treatment of any kind.
By purchasing or using RUO materials, you acknowledge that they will be handled only within an appropriate research environment by qualified personnel who understand the risks, limitations, and regulatory requirements associated with experimental compounds. Products must not be administered to humans or animals, offered as therapeutic agents, or represented as safe or effective for any medical purpose.
Use of these materials is entirely at your own risk. Nivo Labs assume no liability for misuse, unsafe handling, improper application, or any regulatory or compliance issues arising from their use.
